Pulmonary embolism in pediatric age: A retrospective study from a tertiary center

Raquel Lopes de Bragança1,2, Vanessa Gorito1,2,3, Diana Gonçalves Cibele4

  • 1Department of Pediatrics, Centro Hospitalar Universitário de São João, Porto, Portugal.

Pediatric Pulmonology
|June 16, 2021
PubMed

Insights

Pediatric pulmonary embolism (PE) is rare but often missed. Adult diagnostic scores show higher sensitivity than pediatric ones, suggesting a need for improved pediatric PE diagnostic tools and consideration of family history.

Area of Science:

  • Medical research
  • Pediatric medicine
  • Cardiology

Background:

  • Pediatric pulmonary embolism (PE) is an uncommon but serious condition.
  • Accurate and timely diagnosis of PE in children is challenging.

Purpose of the Study:

  • To characterize pediatric pulmonary embolism cases in a tertiary hospital.
  • To evaluate the sensitivity of various diagnostic prediction tools for pediatric PE.

Main Methods:

  • Retrospective descriptive study of 29 PE cases (2008-2020).
  • Analysis of patient demographics, risk factors, clinical presentation, management, and outcomes.
  • Application and comparison of adult and pediatric PE diagnostic prediction tools.

Main Results:

  • Most pediatric PE cases were central, massive, or submassive.
  • Outpatient risk factors included contraceptives and thrombophilia; inpatient factors included immobilization and chronic diseases.
  • Adult diagnostic scores demonstrated higher sensitivity (92.9%-96%) compared to pediatric scores (85.7%-92.9%).

Conclusions:

  • Pediatric PE diagnosis is frequently delayed or missed.
  • Development of pediatric-specific diagnostic tools, potentially adapted from adult scores, is warranted.
  • Clinical presentation and risk factors differ between pediatric outpatients and inpatients; family history should be more broadly considered.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
81
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
209
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
102
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
69
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49